可加佐辛

可加佐辛
臨床資料
ATC碼	未分配;
識別資訊
	IUPAC命名法 3-(cyclobutylmethyl)-6-ethyl-11,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol; ;
CAS號	57653-29-9
PubChem CID	198576;
ChemSpider	171872;
UNII	6GKB767I3M;
ChEMBL	ChEMBL2104583;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID80866641 ;
化學資訊
化學式	C21H31NO
摩爾質量	313.49 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES Oc1ccc4c(c1)C2(C(C(N(CC2)CC3CCC3)C4)(C)C)CC;
	InChI InChI=1S/C21H31NO/c1-4-21-10-11-22(14-15-6-5-7-15)19(20(21,2)3)12-16-8-9-17(23)13-18(16)21/h8-9,13,15,19,23H,4-7,10-12,14H2,1-3H3; Key:IUUBFDSJJHOTDI-UHFFFAOYSA-N;

可加佐辛（INN：cogazocine）是一種含氮有機化合物，分子式C₂₁H₃₁NO，屬於苯嗎喃類衍生物，可用作類阿片鎮痛藥，從未上市銷售^[1]^[2].

參考文獻

^ World Health Organization. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance (PDF). 2004 [2024-06-05]. （原始內容存檔 (PDF)於2011-02-22）.
^ James RW, Heywood R, Crook D. Reversible suppression of spermiogenesis in beagle dogs following overdosage with the narcotic analgesic cogazocine lactate. Toxicology. 1980, 16 (3): 193–203. PMID 6106974. doi:10.1016/0300-483x(80)90116-x.